BristolMyers Squibb Company Celegne Contingent Value Rights
$0.12
+0.02 (+21.21%)
Price as of Oct 14, 2026 market close
Performance
- 1 Month
- +12.1%
- 3 Months
- +1.7%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Jun 2026
- -33.8%
Own CELGR?
See how CELGR contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.